Mirum Pharmaceuticals, Inc. Common Stock MIRM
$100.36
+1.61%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | Insider transaction | 2026-08-12 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-08-05 | View → |
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-05 | View → |
| 4 | Insider transaction | 2026-07-08 | View → |
| 4 | Insider transaction | 2026-07-08 | View → |
| 4 | Insider transaction | 2026-07-02 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 8-K | 8-K | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-08 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-05-18 | View → |
| 8-K | 8-K | 2026-05-18 | View → |
| 10-Q | 10-Q | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-04 | View → |
| 8-K | 8-K | 2026-04-27 | View → |
| DEF 14A | DEF 14A | 2026-04-23 | View → |
| 4 | Insider transaction | 2026-04-16 | View → |
| 4 | Insider transaction | 2026-03-17 | View → |
| 4 | Insider transaction | 2026-03-17 | View → |
| 4 | Insider transaction | 2026-03-17 | View → |
| 4 | Insider transaction | 2026-03-17 | View → |
| 4 | Insider transaction | 2026-03-17 | View → |
| 4 | Insider transaction | 2026-03-17 | View → |
| 4 | Insider transaction | 2026-03-11 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $100.36
- Market Cap
- $6.04 billion
- 52-Week Range
- $50.25 – $130.00
- Average Volume
- 706K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.